What is hypoplastic bone marrow?

Bone marrow is the body’s most vital hematopoietic organ. Based on the ratio of nucleated cells to mature red blood cells in bone marrow, marrow cellularity is classified into five grades: markedly hypercellular, hypercellular, normocellular, hypocellular, and markedly hypocellular. So, what exactly is “hypocellular bone marrow”? Below, we address this question.

What Is Hypocellular Bone Marrow?

Both hypocellular and markedly hypocellular bone marrow fall under the umbrella term “hypocellular bone marrow.” Generally, hypocellular bone marrow is most commonly associated with aplastic anemia, but it may also occur in rare cases of hypoplastic leukemia, malignancies, or during chemotherapy for leukemia or other cancers—when bone marrow function is severely suppressed.

In hypocellular bone marrow, patients often develop pancytopenia in peripheral blood, manifesting clinically as anemia, infections, and bleeding. Therefore, symptomatic management is critically important: red blood cell transfusions and platelet transfusions help correct these clinical manifestations; broad-spectrum antibiotics are used to control infections; and, crucially, the underlying cause of marrow hypocellularity must be identified and treated accordingly. For example, in aplastic anemia, hematopoietic stimulation with androgens may be employed; in acute leukemia, low-dose chemotherapy is indicated; and if marrow suppression results from chemotherapy for malignancy or leukemia, adequate time must be allowed for spontaneous marrow recovery.

The above provides an overview of what hypocellular bone marrow is. We hope this information is helpful to you.